CEC Capital Tops the China-fof "2023 Best FA Institutions TOP 10" List

Today, the China-fof 2023 annual list was officially released, with CEC Capital securing the top position in the "2023 Best FA Institutions TOP 10" list.

This ranking is based on data statistics and research analysis over the past three years. From 2021 to 2023, CEC Capital closed several significant mergers and acquisitions, including Hygeia Healthcare's acquisition of Suzhou Yongding Hospital, valued at RMB 17.3 billion. Other notable transactions include the sale of Colombia China's clinic business to South Yan Group, a strategic cooperation agreement between BIOMERIEUX and ACCUNOME, and substantial financing transactions such as Wenheyou's B-round of RMB 2 billion, Peak's strategic financing of RMB 1.5 billion, Thousand Oaks' strategic financing of RMB 1.5 billion, Beijing Health Guard Biotechnology's pre-IPO financing of over RMB 1 billion, Berry Oncology's B-round financing of over RMB 700 million, and Xinvanda's substantial financing of RMB 1.65 billion.